The U.S. government on Friday proposed 2026 reimbursement rates for Medicare Advantage plans run by private insurers that ...

Financial support options for Paxlovid are changing, but remain in place this winter for Medicare recipients and for others ...

Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, ...

Below is a roundup of payer-centric news headlines you may have missed during the month of January 2025. | You may have ...

More than two years after the passage of the Inflation Reduction Act (“IRA”) and the Centers for Medicare and Medicaid Services’ (“CMS’”) ...

A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found ...

Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to ...

MA plans are substantially overpaid compared to traditional Medicare. Much of these overpayments benefit the MA plans rather ...

Concurrently, a preprint from the industry-backed Vital Transformation found a 50% drop in company investments into ...

It’s the dawn of a new age as Medicare enrollees will be able to save a lot of money on their prescription drugs. “For those ...

Seniors have benefitted from Medicare for 60 years, but recent decades of privatization threaten the integrity of the program ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...